Your session is about to expire
← Back to Search
Arm A: Exercise Intervention for Breast Cancer
Study Summary
This trial aims to understand how exercise can reduce the risk of breast cancer in women with dense breast tissue by studying changes in breast tissue and blood. Participants will be divided into two groups: the Exercise Training
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
What are the principal goals that this medical study aims to achieve?
"The primary aim of this investigation, to be assessed at baseline and week 12 over a period of up to 16 weeks, is the alteration in Irisin levels within the Exercise Group. Additional objectives consist of evaluating the 10-Repetition Max Test results among participants engaging in exercise, which delineates the maximum weight lifted for ten repetitions. The analysis will involve determining changes and relative percent alterations then comparing them between interventions through Wilcoxon rank-sum testing. Furthermore, assessments include variations in Biomarkers within the Exercise Group using Meso Scale technology for detecting inflammatory agents at Dana-Farber Cancer Institute's Translational Research Laboratory. Additionally,"
Which individuals are eligible for participation in this research study?
"To qualify for enrollment, patients must have a diagnosis of breast carcinoma and fall between the ages of 18 and 59. The study is currently seeking to admit a total of 46 individuals."
Are there any available positions for participants in this research study?
"As per clinicaltrials.gov, recruitment for this research endeavor is currently inactive. The trial was initially listed on March 1st, 2024, with the most recent update occurring on March 19th, 2024. Despite the lack of active recruitment for this particular study, it's worth noting that there are a substantial 2703 alternative trials actively seeking participants at present."
Are individuals older than 18 years eligible to participate in this study?
"Individuals aged over 18 years and under 59 years are eligible for recruitment into this clinical trial."
Share this study with friends
Copy Link
Messenger